• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症患者心肺适能与不良心血管结局风险的关联:一项队列研究

Association of cardiorespiratory fitness with risk of adverse cardiovascular outcomes in cancer patients: a cohort study.

作者信息

Wang Yutong, Song Xinyang, Xu Tao, Chen Yanwen, Guo Ying, Wang Fang

机构信息

Cardiology Department, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

Cardiology Department, Peking University Fifth School of Clinical Medicine, Beijing, China.

出版信息

Front Cardiovasc Med. 2025 May 22;12:1569944. doi: 10.3389/fcvm.2025.1569944. eCollection 2025.

DOI:10.3389/fcvm.2025.1569944
PMID:40476141
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12137253/
Abstract

BACKGROUND

Cardiorespiratory fitness (CRF) has gained attention for its potential association with cardiovascular risks. This study aims to examine the association between CRF and adverse cardiovascular outcomes [atrial fibrillation (AF), heart failure (HF), cancer therapy-related cardiovascular toxicity (CTR-CVT)] in cancer patients and explore whether enhancing CRF could improve these outcomes.

METHODS

The association between three key exposure factors of CRF-resting heart rate (RHR), maximum heart rate (HRmax), and maximal oxygen uptake (V̇O)-and the risk of adverse cardiovascular outcomes were assessed using Cox regression analysis.

RESULTS

RHR is significantly associated with an increased risk of adverse events (HF: HR = 1.013, 95% CI 1.008-1.019,  < 0.001; CTR_CVT: HR = 1.006, 95% CI 1.004-1.008,  < 0.001), except for AF (HR = 0.998, 95% CI 0.994-1.001,  = 0.194). HRmax was associated with a lower risk of CTR_CVT events (HR = 0.995, 95% CI 0.993-0.998,  < 0.001), but this was not the case for HF and AF (HF: HR = 1.000, 95% CI 0.992-1.009,  = 0.962; AF: HR = 0.998, 95% CI 0.992-1.003,  = 0.420). V̇O was negatively correlated with all adverse events, with HRs ranging from 0.957 to 0.958 ( < 0.05 for all). RHR showed a significant non-linear relationship with CTR_CVT (Pnon-linear < 0.0001), AF (Pnon-linear < 0.0001), and HF (Pnon-linear = 0.0057). Similarly, V̇O demonstrated a notable non-linear relationship with CTR_CVT (Pnon-linear = 0.0081) and AF (Pnon-linear = 0.0093). No non-linear relationship between HRmax and the outcomes was observed.

CONCLUSION

Cardiorespiratory fitness, as measured by V̇O, is consistently negatively correlated with all adverse cardiovascular outcomes, suggesting that higher fitness levels are protective. These findings highlight the potential role of CRF in predicting cardiovascular risks in cancer patients, underscoring the importance of monitoring and improving physical fitness to mitigate adverse outcomes.

摘要

背景

心肺适能(CRF)因其与心血管风险的潜在关联而受到关注。本研究旨在探讨癌症患者中CRF与不良心血管结局[心房颤动(AF)、心力衰竭(HF)、癌症治疗相关心血管毒性(CTR-CVT)]之间的关联,并探讨增强CRF是否能改善这些结局。

方法

使用Cox回归分析评估CRF的三个关键暴露因素——静息心率(RHR)、最大心率(HRmax)和最大摄氧量(V̇O)——与不良心血管结局风险之间的关联。

结果

RHR与不良事件风险增加显著相关(HF:HR = 1.013,95%置信区间1.008 - 1.019,P < 0.001;CTR_CVT:HR = 1.006,95%置信区间1.004 - 1.008,P < 0.001),AF除外(HR = 0.998,95%置信区间0.994 - 1.001,P = 0.194)。HRmax与CTR_CVT事件风险较低相关(HR = 0.995,95%置信区间0.993 - 0.998,P < 0.001),但HF和AF并非如此(HF:HR = 1.000,95%置信区间0.992 - 1.009,P = 0.962;AF:HR = 0.998,95%置信区间0.992 - 1.003,P = 0.420)。V̇O与所有不良事件呈负相关,HR范围为0.957至0.958(所有P < 0.05)。RHR与CTR_CVT(P非线性 <

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54da/12137253/e32f48e4c8b9/fcvm-12-1569944-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54da/12137253/fe08a118cb04/fcvm-12-1569944-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54da/12137253/e32f48e4c8b9/fcvm-12-1569944-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54da/12137253/fe08a118cb04/fcvm-12-1569944-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54da/12137253/e32f48e4c8b9/fcvm-12-1569944-g002.jpg

相似文献

1
Association of cardiorespiratory fitness with risk of adverse cardiovascular outcomes in cancer patients: a cohort study.癌症患者心肺适能与不良心血管结局风险的关联:一项队列研究
Front Cardiovasc Med. 2025 May 22;12:1569944. doi: 10.3389/fcvm.2025.1569944. eCollection 2025.
2
Associations between physical activity and cardiorespiratory fitness and adverse outcomes in patients with atrial fibrillation: a prospective cohort study.体力活动与心肺适能和心房颤动患者不良结局之间的关联:一项前瞻性队列研究。
Front Cardiovasc Med. 2025 Apr 7;12:1570026. doi: 10.3389/fcvm.2025.1570026. eCollection 2025.
3
Long-term and real-life incidence of cancer therapy-related cardiovascular toxicity in patients with breast cancer: a Swedish cohort study.乳腺癌患者癌症治疗相关心血管毒性的长期及实际发生率:一项瑞典队列研究
Front Oncol. 2023 Apr 19;13:1095251. doi: 10.3389/fonc.2023.1095251. eCollection 2023.
4
Cardiorespiratory fitness and atrial fibrillation: A population-based follow-up study.心肺适能与心房颤动:一项基于人群的随访研究。
Heart Rhythm. 2015 Jul;12(7):1424-30. doi: 10.1016/j.hrthm.2015.03.024. Epub 2015 Mar 14.
5
Long-Term Change in Cardiorespiratory Fitness in Relation to Atrial Fibrillation and Heart Failure (from the Kuopio Ischemic Heart Disease Risk Factor Study).与心房颤动和心力衰竭相关的心肺适能长期变化(来自库奥皮奥缺血性心脏病危险因素研究)
Am J Cardiol. 2018 Apr 15;121(8):956-960. doi: 10.1016/j.amjcard.2018.01.003. Epub 2018 Feb 2.
6
The relationship of cardiorespiratory fitness, physical activity, and coronary artery calcification to cardiovascular disease events in CARDIA participants.心肺适能、身体活动及冠状动脉钙化与CARDIA研究参与者心血管疾病事件的关系。
Eur J Prev Cardiol. 2025 Jan 6;32(1):52-62. doi: 10.1093/eurjpc/zwae272.
7
Resting heart rate in late adolescence and long term risk of cardiovascular disease in Swedish men.青春期后期的静息心率与瑞典男性心血管疾病的长期风险。
Int J Cardiol. 2018 May 15;259:109-115. doi: 10.1016/j.ijcard.2018.01.110.
8
Cardiorespiratory fitness and risk of heart failure: a population-based follow-up study.心肺适能与心力衰竭风险:一项基于人群的随访研究。
Eur J Heart Fail. 2014 Feb;16(2):180-8. doi: 10.1111/ejhf.37. Epub 2013 Dec 14.
9
Physical activity, cardiorespiratory fitness, and cardiovascular outcomes in individuals with atrial fibrillation: the HUNT study.心房颤动患者的体力活动、心肺适能与心血管结局:HUNT研究
Eur Heart J. 2020 Apr 14;41(15):1467-1475. doi: 10.1093/eurheartj/ehaa032.
10
The relationship between maximum heart rate in a cardiorespiratory fitness test and in a maximum heart rate test.心肺功能测试中的最大心率与最大心率测试中的最大心率之间的关系。
J Sci Med Sport. 2019 May;22(5):607-610. doi: 10.1016/j.jsams.2018.11.018. Epub 2018 Nov 28.

本文引用的文献

1
An update on the European Society of Cardiology Council of Cardio-Oncology.欧洲心脏病学会心脏肿瘤学委员会的最新情况。
Eur Heart J. 2025 Apr 22;46(16):1466-1468. doi: 10.1093/eurheartj/ehaf052.
2
Cardiovascular Considerations After Cancer Therapy: Gaps in Evidence and Expert Panel Recommendations.癌症治疗后的心血管问题:证据空白与专家小组建议
JACC CardioOncol. 2025 Jan 21;7(1):1-19. doi: 10.1016/j.jaccao.2024.06.006. eCollection 2025 Jan.
3
Epigenomics of Cardio-Oncology.心脏肿瘤学的表观基因组学
JACC CardioOncol. 2024 Sep 10;6(5):743-745. doi: 10.1016/j.jaccao.2024.07.013. eCollection 2024 Oct.
4
Autonomic Dysfunction Among Adult Survivors of Childhood Cancer in the St. Jude Lifetime Cohort Study.圣犹大儿童研究医院终身队列研究中儿童癌症成年幸存者的自主神经功能障碍
JACC CardioOncol. 2024 Oct 8;6(5):775-787. doi: 10.1016/j.jaccao.2024.08.005. eCollection 2024 Oct.
5
Multicohort Epigenome-Wide Association Study of All-Cause Cardiovascular Disease and Cancer Incidence: A Cardio-Oncology Approach.全因心血管疾病和癌症发病率的多队列表观基因组关联研究:一种心脏肿瘤学方法。
JACC CardioOncol. 2024 Sep 10;6(5):731-742. doi: 10.1016/j.jaccao.2024.07.014. eCollection 2024 Oct.
6
Low energy availability increases immune cell formation of reactive oxygen species and impairs exercise performance in female endurance athletes.低能量供给会增加免疫细胞内活性氧的形成,从而损害女性耐力运动员的运动表现。
Redox Biol. 2024 Sep;75:103250. doi: 10.1016/j.redox.2024.103250. Epub 2024 Jun 19.
7
Unraveling the link between cardiorespiratory fitness and cancer: a state-of-the-art review.解析心肺适能与癌症之间的联系:最新综述。
Geroscience. 2024 Dec;46(6):5559-5585. doi: 10.1007/s11357-024-01222-z. Epub 2024 Jun 3.
8
Biological basis and treatment of frailty and sarcopenia.衰弱和肌少症的生物学基础和治疗。
Cardiovasc Res. 2024 Jul 31;120(9):982-998. doi: 10.1093/cvr/cvae073.
9
Cardiovascular toxicity of immune therapies for cancer.癌症免疫疗法的心血管毒性。
BMJ. 2024 May 15;385:e075859. doi: 10.1136/bmj-2023-075859.
10
Coexisting atrial fibrillation and cancer: time trends and associations with mortality in a nationwide Dutch study.共存的心房颤动和癌症:一项全国性荷兰研究中的时间趋势及其与死亡率的关系。
Eur Heart J. 2024 Jul 9;45(25):2201-2213. doi: 10.1093/eurheartj/ehae222.